Micro Array Patches – Background and Case Study
Get insight in the development of an Interferon-ß containing MAP (Micro Array Patch) and the performance of two prototypes in a pre-clinical study.
Dr Michael Hoffmann is a new member of the Supervisory Board of LTS LOHMANN Therapie-Systeme AG
Dr. Michael Hoffmann was elected to succeed Oliver Hopp as a new member of the LTS Supervisory Board.
Microarray patches show new promise on path to patient-centric medicine
Dr. Frank Theobald verrät, wie positive Studienergebnisse, ein beschleunigter API-Screening-Service und kontinuierliche Formatinnovationen die Tür zu neuen Behandlungsmöglichkeiten mit Microarray-Pflastern öffnen.
Interview with Dr. Mike Schaefers, Chief Commercial Officer at LTS
Dr. Mike Schaefers shares his initial reflections on the company’s hybrid proposition, how it supports customer demand, and how the LTS culture keeps patient need at its core.
LTS takes next step in its Growth Journey with the acquisition of Tapemark Inc.
LTS LOHMANN Therapie-Systeme AG announces the closing of the acquisition of Tapemark Inc. located in St. Paul, MN, USA.
LTS-Academy: OTF as a viable dosage form for pain relief
Our LTS Academy session reports on the latest research in the field of pain and ketamine.
S-ketamine oral thin film – population pharmacokinetics and pharmacodynamics of S-ketamine, S-norketamine and S-hydroxynorketamine
Ketamine is a versatile drug administered via various routes, predominantly intravenously, for a variety of indications, including anesthesia, pain relief and treatment of depression.
LTS invests more than 3 million euros in environmental protection at the Andernach site!
With a new regenerative thermal oxidizer, the company saves about 1.5 million kWh per year.
In vitro to in vivo: De-risking the critical path from laboratory to clinical trial for transdermal therapies
Even the Egyptians explored the topical application of creams for the treatment of skin diseases and for systemic pain relief.
LTS ACADEMY: Introducing Oral Thin Films as a viable dosage form for a pain relief
In our LTS Academy session we will report on the [...]